In addition, in prostate and breast cancer, the expression of S100A11 is significantly associated with high pathologic cancer stage, suggesting that S100A11 is involved in cancer development and progression (Rehman et al., 2004; Cross et al., 2005). Here, S100A11 is linked to breast cancer.